 | • レポートコード：20QY06-04189 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、モンテルカスト薬のグローバル市場について種類別（錠剤、チュアブル錠、経口顆粒）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・モンテルカスト薬市場の概要 ・世界の主要地域別モンテルカスト薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のモンテルカスト薬市場規模2015-2026：種類別（錠剤、チュアブル錠、経口顆粒） ・世界のモンテルカスト薬市場規模2015-2026：用途別（病院、薬局、その他） ・モンテルカスト薬の北米市場規模2015-2020 ・モンテルカスト薬のヨーロッパ市場規模2015-2020 ・モンテルカスト薬の中国市場規模2015-2020 ・モンテルカスト薬の日本市場規模2015-2020 ・モンテルカスト薬の東南アジア市場規模2015-2020 ・モンテルカスト薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck & Co.、Teva、Mylan、Glenmark Pharmaceuticals、Hikma Group、Sandoz、Torrent Pharmaceuticals、Lannett Company、Apotex、Dr. Reddys Laboratories、Aurobindo Pharma、Accord Healthcare、Hetero、Unimark、Ajanta Pharma、MACLEODS、Jubilant Pharma、Unichem Laboratories、Amneal Pharmaceuticals、Shanghai Anbison Lab、Perrigo、Cipla、CSPC Ouyi Pharmaceutical） ・モンテルカスト薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・モンテルカスト薬の市場動向・機会・課題 ・調査の結論 |
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
Market Analysis and Insights: Global Montelukast Drug Market
The global Montelukast Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Montelukast Drug Scope and Market Size
The global Montelukast Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Montelukast Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Montelukast Drug market is segmented into
Tablet
Chewable tablet
Oral Granules
Segment by Application, the Montelukast Drug market is segmented into
Hospital
Drug store
Others
The Montelukast Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Montelukast Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Montelukast Drug Market Share Analysis
Montelukast Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Montelukast Drug business, the date to enter into the Montelukast Drug market, Montelukast Drug product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Table of Contents
1 Montelukast Drug Market Overview
1.1 Montelukast Drug Product Scope
1.2 Montelukast Drug Segment by Type
1.2.1 Global Montelukast Drug Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Chewable tablet
1.2.4 Oral Granules
1.3 Montelukast Drug Segment by Application
1.3.1 Global Montelukast Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drug store
1.3.4 Others
1.4 Montelukast Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Montelukast Drug Sales Growth Rate (2015-2026)
1.4.2 Global Montelukast Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Montelukast Drug Price Trends (2015-2026)
2 Montelukast Drug Estimate and Forecast by Region
2.1 Global Montelukast Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Montelukast Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Montelukast Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Montelukast Drug Revenue Market Share by Region (2015-2020)
2.3 Global Montelukast Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Montelukast Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Montelukast Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Montelukast Drug Estimates and Projections (2015-2026)
2.4.2 Europe Montelukast Drug Estimates and Projections (2015-2026)
2.4.3 China Montelukast Drug Estimates and Projections (2015-2026)
2.4.4 Japan Montelukast Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Montelukast Drug Estimates and Projections (2015-2026)
2.4.6 India Montelukast Drug Estimates and Projections (2015-2026)
3 Global Montelukast Drug Competition Landscape by Players
3.1 Global Top Montelukast Drug Players by Sales (2015-2020)
3.2 Global Top Montelukast Drug Players by Revenue (2015-2020)
3.3 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Drug as of 2019)
3.4 Global Montelukast Drug Average Price by Company (2015-2020)
3.5 Manufacturers Montelukast Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Montelukast Drug Players (Opinion Leaders)
4 Global Montelukast Drug Market Size by Type
4.1 Global Montelukast Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Montelukast Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Montelukast Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Montelukast Drug Price by Type (2014-2020)
4.2 Global Montelukast Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Montelukast Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Montelukast Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Montelukast Drug Price Forecast by Type (2021-2026)
5 Global Montelukast Drug Market Size by Application
5.1 Global Montelukast Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Montelukast Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Montelukast Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Montelukast Drug Price by Application (2015-2020)
5.2 Global Montelukast Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Montelukast Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Montelukast Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Montelukast Drug Price Forecast by Application (2021-2026)
3 North America Montelukast Drug Market Facts & Figures
3.2 North America Montelukast Drug Sales Market Share by Company (2015-2020)
3.3 North America Montelukast Drug Sales Market Share by Type (2015-2020)
3.4 North America Montelukast Drug Sales Market Share by Application (2015-2020)
4 Europe Montelukast Drug Market Facts & Figures
4.2 Europe Montelukast Drug Sales Market Share by Company (2015-2020)
4.3 Europe Montelukast Drug Sales Market Share by Type (2015-2020)
4.4 Europe Montelukast Drug Sales Market Share by Application (2015-2020)
5 China Montelukast Drug Market Facts & Figures
5.2 China Montelukast Drug Sales Market Share by Company (2015-2020)
5.3 China Montelukast Drug Sales Market Share by Type (2015-2020)
5.4 China Montelukast Drug Sales Market Share by Application (2015-2020)
6 Japan Montelukast Drug Market Facts & Figures
6.2 Japan Montelukast Drug Sales Market Share by Company (2015-2020)
6.3 Japan Montelukast Drug Sales Market Share by Type (2015-2020)
6.4 Japan Montelukast Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Montelukast Drug Market Facts & Figures
7.2 Southeast Asia Montelukast Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Montelukast Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Montelukast Drug Sales Market Share by Application (2015-2020)
8 India Montelukast Drug Market Facts & Figures
8.2 India Montelukast Drug Sales Market Share by Company (2015-2020)
8.3 India Montelukast Drug Sales Market Share by Type (2015-2020)
8.4 India Montelukast Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Montelukast Drug Business
12.1 Merck & Co.
12.1.1 Merck & Co. Montelukast Drug Corporation Information
12.1.2 Merck & Co. Montelukast Drug Business Overview and Total Revenue
12.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co. Montelukast Drug Products Offered
12.1.5 Merck & Co. Recent Development
12.2 Teva
12.2.1 Teva Montelukast Drug Corporation Information
12.2.2 Teva Montelukast Drug Business Overview and Total Revenue
12.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Montelukast Drug Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Montelukast Drug Corporation Information
12.3.2 Mylan Montelukast Drug Business Overview and Total Revenue
12.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Montelukast Drug Products Offered
12.3.5 Mylan Recent Development
12.4 Glenmark Pharmaceuticals
12.4.1 Glenmark Pharmaceuticals Montelukast Drug Corporation Information
12.4.2 Glenmark Pharmaceuticals Montelukast Drug Business Overview and Total Revenue
12.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
12.4.5 Glenmark Pharmaceuticals Recent Development
12.5 Hikma Group
12.5.1 Hikma Group Montelukast Drug Corporation Information
12.5.2 Hikma Group Montelukast Drug Business Overview and Total Revenue
12.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hikma Group Montelukast Drug Products Offered
12.5.5 Hikma Group Recent Development
12.6 Sandoz
12.6.1 Sandoz Montelukast Drug Corporation Information
12.6.2 Sandoz Montelukast Drug Business Overview and Total Revenue
12.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sandoz Montelukast Drug Products Offered
12.6.5 Sandoz Recent Development
12.7 Torrent Pharmaceuticals
12.7.1 Torrent Pharmaceuticals Montelukast Drug Corporation Information
12.7.2 Torrent Pharmaceuticals Montelukast Drug Business Overview and Total Revenue
12.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
12.7.5 Torrent Pharmaceuticals Recent Development
12.8 Lannett Company
12.8.1 Lannett Company Montelukast Drug Corporation Information
12.8.2 Lannett Company Montelukast Drug Business Overview and Total Revenue
12.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lannett Company Montelukast Drug Products Offered
12.8.5 Lannett Company Recent Development
12.9 Apotex
12.9.1 Apotex Montelukast Drug Corporation Information
12.9.2 Apotex Montelukast Drug Business Overview and Total Revenue
12.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Apotex Montelukast Drug Products Offered
12.9.5 Apotex Recent Development
12.10 Dr. Reddys Laboratories
12.10.1 Dr. Reddys Laboratories Montelukast Drug Corporation Information
12.10.2 Dr. Reddys Laboratories Montelukast Drug Business Overview and Total Revenue
12.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
12.10.5 Dr. Reddys Laboratories Recent Development
12.11 Aurobindo Pharma
12.11.1 Aurobindo Pharma Montelukast Drug Corporation Information
12.11.2 Aurobindo Pharma Montelukast Drug Business Overview and Total Revenue
12.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Aurobindo Pharma Montelukast Drug Products Offered
12.11.5 Aurobindo Pharma Recent Development
12.12 Accord Healthcare
12.12.1 Accord Healthcare Montelukast Drug Corporation Information
12.12.2 Accord Healthcare Montelukast Drug Business Overview and Total Revenue
12.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Accord Healthcare Montelukast Drug Products Offered
12.12.5 Accord Healthcare Recent Development
12.13 Hetero
12.13.1 Hetero Montelukast Drug Corporation Information
12.13.2 Hetero Montelukast Drug Business Overview and Total Revenue
12.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hetero Montelukast Drug Products Offered
12.13.5 Hetero Recent Development
12.14 Unimark
12.14.1 Unimark Montelukast Drug Corporation Information
12.14.2 Unimark Montelukast Drug Business Overview and Total Revenue
12.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Unimark Montelukast Drug Products Offered
12.14.5 Unimark Recent Development
12.15 Ajanta Pharma
12.15.1 Ajanta Pharma Montelukast Drug Corporation Information
12.15.2 Ajanta Pharma Montelukast Drug Business Overview and Total Revenue
12.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ajanta Pharma Montelukast Drug Products Offered
12.15.5 Ajanta Pharma Recent Development
12.16 MACLEODS
12.16.1 MACLEODS Montelukast Drug Corporation Information
12.16.2 MACLEODS Montelukast Drug Business Overview and Total Revenue
12.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 MACLEODS Montelukast Drug Products Offered
12.16.5 MACLEODS Recent Development
12.17 Jubilant Pharma
12.17.1 Jubilant Pharma Montelukast Drug Corporation Information
12.17.2 Jubilant Pharma Montelukast Drug Business Overview and Total Revenue
12.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Jubilant Pharma Montelukast Drug Products Offered
12.17.5 Jubilant Pharma Recent Development
12.18 Unichem Laboratories
12.18.1 Unichem Laboratories Montelukast Drug Corporation Information
12.18.2 Unichem Laboratories Montelukast Drug Business Overview and Total Revenue
12.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Unichem Laboratories Montelukast Drug Products Offered
12.18.5 Unichem Laboratories Recent Development
12.19 Amneal Pharmaceuticals
12.19.1 Amneal Pharmaceuticals Montelukast Drug Corporation Information
12.19.2 Amneal Pharmaceuticals Montelukast Drug Business Overview and Total Revenue
12.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Amneal Pharmaceuticals Montelukast Drug Products Offered
12.19.5 Amneal Pharmaceuticals Recent Development
12.20 Shanghai Anbison Lab
12.20.1 Shanghai Anbison Lab Montelukast Drug Corporation Information
12.20.2 Shanghai Anbison Lab Montelukast Drug Business Overview and Total Revenue
12.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Shanghai Anbison Lab Montelukast Drug Products Offered
12.20.5 Shanghai Anbison Lab Recent Development
12.21 Perrigo
12.21.1 Perrigo Montelukast Drug Corporation Information
12.21.2 Perrigo Montelukast Drug Business Overview and Total Revenue
12.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Perrigo Montelukast Drug Products Offered
12.21.5 Perrigo Recent Development
12.22 Cipla
12.22.1 Cipla Montelukast Drug Corporation Information
12.22.2 Cipla Montelukast Drug Business Overview and Total Revenue
12.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cipla Montelukast Drug Products Offered
12.22.5 Cipla Recent Development
12.23 CSPC Ouyi Pharmaceutical
12.23.1 CSPC Ouyi Pharmaceutical Montelukast Drug Corporation Information
12.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Business Overview and Total Revenue
12.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2015-2020)
12.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products Offered
12.23.5 CSPC Ouyi Pharmaceutical Recent Development
13 Montelukast Drug Manufacturing Cost Analysis
13.1 Montelukast Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Montelukast Drug
13.4 Montelukast Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Montelukast Drug Distributors List
14.3 Montelukast Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Montelukast Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Montelukast Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Montelukast Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Montelukast Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Montelukast Drug Sales Market Share by Region (2015-2020)
Table 6. Global Montelukast Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Montelukast Drug Revenue Share by Region (2015-2020)
Table 8. Global Montelukast Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Montelukast Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Montelukast Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Montelukast Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Montelukast Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Montelukast Drug Sales Share by Company (2015-2020)
Table 14. Global Montelukast Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Montelukast Drug Revenue Share by Company (2015-2020)
Table 16. Global Montelukast Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Drug as of 2019)
Table 17. Global Montelukast Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Montelukast Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Montelukast Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Montelukast Drug Players
Table 22. Global Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Montelukast Drug Sales Share by Type (2015-2020)
Table 24. Global Montelukast Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Montelukast Drug Price (K MT) by Type (2015-2020)
Table 26. Global Montelukast Drug Sales Share by Type (2021-2026)
Table 27. Global Montelukast Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Montelukast Drug Revenue Share by Type (2021-2026)
Table 29. Global Montelukast Drug Price (K MT) by Type (2021-2026)
Table 30. Global Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Montelukast Drug Sales Share by Application (2015-2020)
Table 32. Global Montelukast Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Montelukast Drug Price (K MT) by Application (2015-2020)
Table 34. Global Montelukast Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Montelukast Drug Sales Share by Application (2021-2026)
Table 36. Global Montelukast Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Montelukast Drug Revenue Share by Application (2021-2026)
Table 38. Global Montelukast Drug Price (K MT) by Application (2021-2026)
Table 39. United States Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Montelukast Drug Sales Market Share by Company (2015-2020)
Table 41. United States Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Montelukast Drug Sales Market Share by Type (2015-2020)
Table 43. United States Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Montelukast Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Montelukast Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Montelukast Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Montelukast Drug Sales Market Share by Type (2015-2020)
Table 51. China Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 52. China Montelukast Drug Sales Market Share by Company (2015-2020)
Table 53. China Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 54. China Montelukast Drug Sales Market Share by Type (2015-2020)
Table 55. China Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 56. China Montelukast Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Montelukast Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Montelukast Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Montelukast Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Montelukast Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Montelukast Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Montelukast Drug Sales Market Share by Application (2015-2020)
Table 69. India Montelukast Drug Sales (K MT) by Company (2015-2020)
Table 70. India Montelukast Drug Sales Market Share by Company (2015-2020)
Table 71. India Montelukast Drug Sales (K MT) by Type (2015-2020)
Table 72. India Montelukast Drug Sales Market Share by Type (2015-2020)
Table 73. India Montelukast Drug Sales (K MT) by Application (2015-2020)
Table 74. India Montelukast Drug Sales Market Share by Application (2015-2020)
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck & Co. Montelukast Drug Product
Table 79. Merck & Co. Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Teva Montelukast Drug Product
Table 84. Teva Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Mylan Montelukast Drug Product
Table 89. Mylan Recent Development
Table 90. Glenmark Pharmaceuticals Corporation Information
Table 91. Glenmark Pharmaceuticals Description and Business Overview
Table 92. Glenmark Pharmaceuticals Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Glenmark Pharmaceuticals Montelukast Drug Product
Table 94. Glenmark Pharmaceuticals Recent Development
Table 95. Hikma Group Corporation Information
Table 96. Hikma Group Description and Business Overview
Table 97. Hikma Group Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Hikma Group Montelukast Drug Product
Table 99. Hikma Group Recent Development
Table 100. Sandoz Corporation Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sandoz Montelukast Drug Product
Table 104. Sandoz Recent Development
Table 105. Torrent Pharmaceuticals Corporation Information
Table 106. Torrent Pharmaceuticals Description and Business Overview
Table 107. Torrent Pharmaceuticals Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Torrent Pharmaceuticals Montelukast Drug Product
Table 109. Torrent Pharmaceuticals Recent Development
Table 110. Lannett Company Corporation Information
Table 111. Lannett Company Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Lannett Company Description and Business Overview
Table 113. Lannett Company Montelukast Drug Product
Table 114. Lannett Company Recent Development
Table 115. Apotex Corporation Information
Table 116. Apotex Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Apotex Description and Business Overview
Table 118. Apotex Montelukast Drug Product
Table 119. Apotex Recent Development
Table 120. Dr. Reddys Laboratories Corporation Information
Table 121. Dr. Reddys Laboratories Description and Business Overview
Table 122. Dr. Reddys Laboratories Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Dr. Reddys Laboratories Montelukast Drug Product
Table 124. Dr. Reddys Laboratories Recent Development
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Aurobindo Pharma Montelukast Drug Product
Table 129. Aurobindo Pharma Recent Development
Table 130. Accord Healthcare Corporation Information
Table 131. Accord Healthcare Description and Business Overview
Table 132. Accord Healthcare Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Accord Healthcare Montelukast Drug Product
Table 134. Accord Healthcare Recent Development
Table 135. Hetero Corporation Information
Table 136. Hetero Description and Business Overview
Table 137. Hetero Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Hetero Montelukast Drug Product
Table 139. Hetero Recent Development
Table 140. Unimark Corporation Information
Table 141. Unimark Description and Business Overview
Table 142. Unimark Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Unimark Montelukast Drug Product
Table 144. Unimark Recent Development
Table 145. Ajanta Pharma Corporation Information
Table 146. Ajanta Pharma Description and Business Overview
Table 147. Ajanta Pharma Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Ajanta Pharma Montelukast Drug Product
Table 149. Ajanta Pharma Recent Development
Table 150. MACLEODS Corporation Information
Table 151. MACLEODS Description and Business Overview
Table 152. MACLEODS Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. MACLEODS Montelukast Drug Product
Table 154. MACLEODS Recent Development
Table 155. Jubilant Pharma Corporation Information
Table 156. Jubilant Pharma Description and Business Overview
Table 157. Jubilant Pharma Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Jubilant Pharma Montelukast Drug Product
Table 159. Jubilant Pharma Recent Development
Table 160. Unichem Laboratories Corporation Information
Table 161. Unichem Laboratories Description and Business Overview
Table 162. Unichem Laboratories Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Unichem Laboratories Montelukast Drug Product
Table 164. Unichem Laboratories Recent Development
Table 165. Amneal Pharmaceuticals Corporation Information
Table 166. Amneal Pharmaceuticals Description and Business Overview
Table 167. Amneal Pharmaceuticals Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Amneal Pharmaceuticals Montelukast Drug Product
Table 169. Amneal Pharmaceuticals Recent Development
Table 170. Shanghai Anbison Lab Corporation Information
Table 171. Shanghai Anbison Lab Description and Business Overview
Table 172. Shanghai Anbison Lab Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Shanghai Anbison Lab Montelukast Drug Product
Table 174. Shanghai Anbison Lab Recent Development
Table 175. Perrigo Corporation Information
Table 176. Perrigo Description and Business Overview
Table 177. Perrigo Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Perrigo Montelukast Drug Product
Table 179. Perrigo Recent Development
Table 180. Cipla Corporation Information
Table 181. Cipla Description and Business Overview
Table 182. Cipla Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Cipla Montelukast Drug Product
Table 184. Cipla Recent Development
Table 185. CSPC Ouyi Pharmaceutical Corporation Information
Table 186. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 187. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. CSPC Ouyi Pharmaceutical Montelukast Drug Product
Table 189. CSPC Ouyi Pharmaceutical Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Montelukast Drug Distributors List
Table 193. Montelukast Drug Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Montelukast Drug Product Picture
Figure 2. Global Montelukast Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Montelukast Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drug store Examples
Figure 8. Others Examples
Figure 9. Global Montelukast Drug Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Montelukast Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Montelukast Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Montelukast Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Montelukast Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Montelukast Drug Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Montelukast Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Montelukast Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Montelukast Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Montelukast Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Montelukast Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Montelukast Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Montelukast Drug Players Market Share by Revenue in Montelukast Drug 2015 & 2019
Figure 27. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Montelukast Drug Revenue Share by Type (2015-2020)
Figure 29. Global Montelukast Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Montelukast Drug Revenue Share by Application (2015-2020)
Figure 31. Global Montelukast Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Montelukast Drug Sales Market Share by Type in 2019
Figure 33. United States Montelukast Drug Sales Market Share by Type in 2019
Figure 34. Europe Montelukast Drug Sales Market Share by Company in 2019
Figure 35. Europe Montelukast Drug Sales Market Share by Type in 2019
Figure 36. Europe Montelukast Drug Sales Market Share by Application in 2019
Figure 37. China Montelukast Drug Sales Market Share by Company in 2019
Figure 38. China Montelukast Drug Sales Market Share by Type in 2019
Figure 39. China Montelukast Drug Sales Market Share by Application in 2019
Figure 40. Japan Montelukast Drug Sales Market Share by Company in 2019
Figure 41. Japan Montelukast Drug Sales Market Share by Type in 2019
Figure 42. Japan Montelukast Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Montelukast Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Montelukast Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Montelukast Drug Sales Market Share by Application in 2019
Figure 46. India Montelukast Drug Sales Market Share by Company in 2019
Figure 47. India Montelukast Drug Sales Market Share by Type in 2019
Figure 48. India Montelukast Drug Sales Market Share by Application in 2019
Figure 49. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Hikma Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Lannett Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Dr. Reddys Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Accord Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Unimark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ajanta Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. MACLEODS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Unichem Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Shanghai Anbison Lab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. CSPC Ouyi Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Key Raw Materials Price Trend
Figure 73. Manufacturing Cost Structure of Montelukast Drug
Figure 74. Manufacturing Process Analysis of Montelukast Drug
Figure 75. Montelukast Drug Industrial Chain Analysis
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Porter's Five Forces Analysis
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…
- オクスカルバゼピン薬の世界市場レポート2020 Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments. Market Analysis and Insights: Global Oxcarbazepine Drug Market The global Oxcar…